Atrium Therapeutics, Inc. — All Filings
24 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | 4 | 0001193125-26-085922 | Mar 2, 2026 | Feb 27, 2026 |
| 4 | 4 | 0001193125-26-085921 | Mar 2, 2026 | Feb 27, 2026 |
| 4 | 4 | 0001193125-26-085920 | Mar 2, 2026 | Feb 27, 2026 |
| 4 | 4 | 0001193125-26-085919 | Mar 2, 2026 | Feb 27, 2026 |
| 4 | 4 | 0001193125-26-085918 | Mar 2, 2026 | Feb 27, 2026 |
| 8-K | 8-K | 0001193125-26-083227 | Feb 27, 2026 | Feb 26, 2026 |
| 3 | 3 | 0001193125-26-077934 | Feb 26, 2026 | — |
| 3 | 3 | 0001193125-26-077907 | Feb 26, 2026 | — |
| 3 | 3 | 0001193125-26-077801 | Feb 26, 2026 | — |
| 3 | 3 | 0001193125-26-077764 | Feb 26, 2026 | — |
| 3 | 3 | 0001193125-26-077763 | Feb 26, 2026 | — |
| 3 | 3 | 0001193125-26-077740 | Feb 26, 2026 | — |
| 3 | 3 | 0001193125-26-077739 | Feb 26, 2026 | — |
| 3 | 3 | 0001193125-26-077733 | Feb 26, 2026 | — |
| 3 | 3 | 0001193125-26-077728 | Feb 26, 2026 | — |
| 3 | 3 | 0001193125-26-077718 | Feb 26, 2026 | — |
| 3 | 3 | 0001193125-26-077716 | Feb 26, 2026 | — |
| 8-K | 8-K | 0001193125-26-077105 | Feb 26, 2026 | — |
| S-8 | S-8 | 0001193125-26-075072 | Feb 26, 2026 | — |
| SEC STAFF ACTION | — | 9999999997-26-000345 | Feb 26, 2026 | — |
| CERT | — | 0001354457-26-000219 | Feb 26, 2026 | — |
| 10-12B/A | 10-12B/A | 0001193125-26-055010 | Feb 17, 2026 | — |
| 10-12B/A | 10-12B/A | 0001193125-26-029976 | Jan 30, 2026 | — |
| 10-12B | 10-12B | 0001193125-25-314415 | Dec 10, 2025 | — |